ID

41386

Beschreibung

Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01925755

Link

https://clinicaltrials.gov/show/NCT01925755

Stichworte

  1. 19.01.19 19.01.19 -
  2. 28.09.20 28.09.20 -
Rechteinhaber

see on clinicaltrials.gov

Hochgeladen am

28. September 2020

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Stroke Secondary to Atrial Fibrillation, NCT01925755

Eligibility Stroke Secondary to Atrial Fibrillation, NCT01925755

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
male and female patients ≥ 18 years old who start treatment with rivaroxaban
Beschreibung

Age, Gender, Start of Rivaroxaban

Datentyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
UMLS CUI [3,1]
C1739768
UMLS CUI [3,2]
C0439659
non-valvular atrial fibrillation is documented in patients' file
Beschreibung

Non-valvular Atrial fibrillation

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0004238
UMLS CUI [1,2]
C0018826
UMLS CUI [1,3]
C1314939
UMLS CUI [1,4]
C0332197
prior tia/stroke history
Beschreibung

Tia/stroke history

Datentyp

boolean

Alias
UMLS CUI [1]
C0559159
UMLS CUI [2]
C0455536
if tia - more than 72 hours after documented tia
Beschreibung

Tia more than 72 hours ago

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0231290
UMLS CUI [1,2]
C0007787
if stroke - more than 2 weeks after non-hemorrhagic stroke
Beschreibung

Non-hemorrhagic stroke more than 2 weeks ago

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0038454
UMLS CUI [1,2]
C0231290
written informed consent
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
contraindications for use of xarelto® in accordance with approved product label
Beschreibung

Contraindications Xarelto®

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1739768
UMLS CUI [1,2]
C0522473
previous thromboprophylaxis treatment for stroke/tia prevention
Beschreibung

Anticoagulant prophylaxis for stroke/tia prevention

Datentyp

boolean

Alias
UMLS CUI [1]
C0199242
UMLS CUI [2,1]
C0948008
UMLS CUI [2,2]
C0199176
UMLS CUI [3,1]
C0007787
UMLS CUI [3,2]
C0199176
any reasons of medical and non-medical character, which in the opinion of the physician can hamper patient participation in nis
Beschreibung

Other reason affecting participation

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3840932
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C2348568
UMLS CUI [1,4]
C0022423
UMLS CUI [1,5]
C0031831

Ähnliche Modelle

Eligibility Stroke Secondary to Atrial Fibrillation, NCT01925755

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age, Gender, Start of Rivaroxaban
Item
male and female patients ≥ 18 years old who start treatment with rivaroxaban
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C1739768 (UMLS CUI [3,1])
C0439659 (UMLS CUI [3,2])
Non-valvular Atrial fibrillation
Item
non-valvular atrial fibrillation is documented in patients' file
boolean
C0004238 (UMLS CUI [1,1])
C0018826 (UMLS CUI [1,2])
C1314939 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
Tia/stroke history
Item
prior tia/stroke history
boolean
C0559159 (UMLS CUI [1])
C0455536 (UMLS CUI [2])
Tia more than 72 hours ago
Item
if tia - more than 72 hours after documented tia
boolean
C0231290 (UMLS CUI [1,1])
C0007787 (UMLS CUI [1,2])
Non-hemorrhagic stroke more than 2 weeks ago
Item
if stroke - more than 2 weeks after non-hemorrhagic stroke
boolean
C0038454 (UMLS CUI [1,1])
C0231290 (UMLS CUI [1,2])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Contraindications Xarelto®
Item
contraindications for use of xarelto® in accordance with approved product label
boolean
C1739768 (UMLS CUI [1,1])
C0522473 (UMLS CUI [1,2])
Anticoagulant prophylaxis for stroke/tia prevention
Item
previous thromboprophylaxis treatment for stroke/tia prevention
boolean
C0199242 (UMLS CUI [1])
C0948008 (UMLS CUI [2,1])
C0199176 (UMLS CUI [2,2])
C0007787 (UMLS CUI [3,1])
C0199176 (UMLS CUI [3,2])
Other reason affecting participation
Item
any reasons of medical and non-medical character, which in the opinion of the physician can hamper patient participation in nis
boolean
C3840932 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C0022423 (UMLS CUI [1,4])
C0031831 (UMLS CUI [1,5])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video